8-K
filed May 14, 2026, 4:31 PM ET
ticker HRMY
CIK 0001802665
other material
confidence high
sentiment neutral
materiality 0.15
Harmony Biosciences shareholders elect four directors, ratify auditor, approve say-on-pay at 2026 annual meeting
Harmony Biosciences Holdings, Inc.
- All four Class III director nominees elected: Geno Germano (44.96M for), Troy Ignelzi (32.81M), Ron Philip (31.83M), Andreas Wicki (25.11M).
- Deloitte & Touche ratified as independent auditor for FY2026 with 49.39M for, 0.83M against, 0.17M abstain.
- Say-on-pay advisory vote approved: 33.25M for, 13.04M against, 0.19M abstain; broker non-votes of 3.89M.
- Quorum of 50.38M shares represented out of outstanding; all proposals passed.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Harmony Biosciences Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-14
Exact text from the filing
Proposal 2. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Harmony Biosciences Holdings, Inc. shareholders approved Election of four Class III directors at the 2026-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-14
Exact text from the filing
Proposal 1. The election of four Class III directors listed below to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Harmony Biosciences Holdings, Inc. shareholders approved Approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers at the 2026-05-14 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-14
Exact text from the filing
Proposal 3. The approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers pursuant to the SEC’s compensation disclosure rules.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.